Coronavirus: Thread

grarpamp grarpamp at gmail.com
Tue Oct 19 22:41:06 PDT 2021


> ivermectin
>
> https://c19early.com/
> https://covid19criticalcare.com/
> https://flccc.net/
> https://c19adoption.com/
> https://ivmmeta.com/
> https://c19ivermectin.com/
> https://ivmstatus.com/
> https://hcqmeta.com/
> https://c19hcq.com/
> https://c19vitamind.com/
> https://vitamindforall.org/
> https://vdmeta.com/
> https://c19zinc.com/


Is Aspirin The New Horse Dewormer?

https://www.americanthinker.com/articles/2021/10/is_aspirin_the_new_horse_dewormer.html
https://mewe.com/p/americanthinkerforum/show/616d8fe26143390768ea659c
by Brian C. Joondeph, MD

https://journals.lww.com/anesthesia-analgesia/Fulltext/2021/04000/Aspirin_Use_Is_Associated_With_Decreased.2.aspx
https://www.jpost.com/health-and-wellness/aspirin-lowers-risk-of-covid-new-findings-support-preliminary-israeli-trial-681127
https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.120.050354
https://www.youtube.com/watch?v=7OZGGoonPGo
https://www.heart.org/en/health-topics/heart-attack/treatment-of-a-heart-attack/aspirin-and-heart-disease
https://pubmed.ncbi.nlm.nih.gov/30391545/
https://www.healthline.com/health/willow-bark-natures-aspirin
https://pubmed.ncbi.nlm.nih.gov/2664509/
https://www.aspirin-foundation.com/history/
https://pubmed.ncbi.nlm.nih.gov/33621437/
https://journals.lww.com/anesthesia-analgesia/Fulltext/2021/04000/Aspirin_in_Coronavirus_Disease_2019_Related_Acute.1.aspx
https://www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/aspirin-cvd-prevention-final-rec-bulletin.pdf
https://www.scientificamerican.com/article/strange-but-true-drinking-too-much-water-can-kill/
https://www.jpost.com/health-and-wellness/aspirin-lowers-risk-of-covid-new-findings-support-preliminary-israeli-trial-681127
https://www.nbcnews.com/health/heart-health/adults-shouldnt-take-daily-aspirin-prevent-heart-attack-panel-says-rcna2869
https://www.nytimes.com/2019/03/18/health/aspirin-health.html
https://www.healthline.com/health-news/you-can-skip-your-daily-aspirin-regimen
https://www.thedailybeast.com/foxs-neil-cavuto-warns-viewers-after-trump-says-hes-taking-hydroxychloroquine-this-will-kill-you
https://www.theguardian.com/commentisfree/2021/oct/14/merck-drug-prices-us-healthcare-big-pharma
https://pubmed.ncbi.nlm.nih.gov/34466270/
https://nypost.com/2021/10/14/joe-rogan-takes-on-sanjay-gupta-over-cnn-lying-about-covid-treatment/
https://www.everydayhealth.com/news/surprising-uses-for-aspirin/

Aspirin is one of those drugs that has been around forever. It is
commonly used as a pain reliever, anti-inflammatory, and blood
thinner. Surprisingly it may also have benefits in treating COVID.

A paper in Anesthesia and Analgesia published last spring titled,
“Aspirin use is associated with decreased mechanical ventilation,
intensive care unit admission, and in-hospital mortality in
hospitalized patients with coronavirus disease 2019.”

This was a retrospective, observational study of adult patients
admitted to multiple hospitals in the U.S. between March and July
2020, in the early days of COVID. The primary outcome addressed by the
researchers from George Washington University was the need for
mechanical ventilation, which then, and still now, carries an
extremely high chance of never leaving the ICU alive.

This was not a gold standard randomized prospective clinical trial.
That would not be feasible in this situation since study patients were
already hospitalized and critically ill. Remember in the early days,
one needed to be extremely ill before even being admitted to the
hospital rather than being sent home until sick enough to return and
go straight to the ICU.

But the results were impressive. As reported last week by the Jerusalem Post,

    The team investigated more than 400 COVID patients from hospitals
across the United States who take aspirin unrelated to their COVID
disease, and found that the treatment reduced the risk of several
parameters by almost half: reaching mechanical ventilation by 44%, ICU
admissions by 43%, and overall in-hospital mortality by 47%.

Why would aspirin be helpful for COVID, a respiratory disease? What if
COVID is more than simply a lung disease or pneumonia? COVID is
actually thought to be a microvascular disease causing blood clots, as
described in the medical journal Circulation,

    Although most patients with coronavirus disease 2019 (COVID-19)
present with a mild upper respiratory tract infection and then
recover, some infected patients develop pneumonia, acute respiratory
distress syndrome, multi-organ failure, and death. Clues to the
pathogenesis of severe COVID-19 may lie in the systemic inflammation
and thrombosis observed in infected patients. We propose that severe
COVID-19 is a microvascular disease in which coronavirus infection
activates endothelial cells, triggering exocytosis, a rapid vascular
response that drives microvascular inflammation and thrombosis.

Note the thrombosis aspect, blood clots forming in the lungs and
elsewhere in the body. Aspirin, as a blood thinner, reduces the risk
of blood clots, explaining its potential benefit for COVID.
YouTube screen grab

For the same reason, the American Heart Association recommends,

    If you have had a heart attack or stroke, your doctor may want you
to take a daily low dose of aspirin to help prevent another. Aspirin
is part of a well-established treatment plan for patients with a
history of heart attack or stroke.

Add the appropriate caveat, which I would echo, “You should not take
daily low-dose aspirin on your own without talking to your doctor. The
risks and benefits vary for each person.”

How did aspirin get its start? Over 3,500 years ago, willow bark,
known as “nature’s aspirin,” was used as a painkiller and antipyretic
by ancient Egyptians and Greeks, and in a chemical synthesis by a
Bayer chemist in 1897.

Aside from pain relief, it was found to have anti-platelet and
anti-cancer effects. It’s also on the World Health Organization’s list
of essential medicines, along with another familiar drug, ivermectin.
The Harvard-based physicians’ health study in the 1980s found that
low-dose aspirin reduced the risk of heart attack by 44 percent.

A recently published Israeli study found, “Aspirin use is associated
with better outcomes among COVID-19 positive patients.” This included
a lower likelihood of infection, disease duration, and hospital
survival. In other words, aspirin works as both a preventative and as
a treatment.

Aspirin is another potential therapeutic, along with
hydroxychloroquine and ivermectin, which is inexpensive, readily
available, and relatively safe, and could save countless lives when
used appropriately for COVID. An editorial in Anesthesia and Analgesia
described aspirin for COVID as, “An old, low-cost therapy with a
strong rationale.” And right on cue, it’s time for aspirin-bashing to
commence.

At the same time as these papers showing potential benefits of aspirin
for COVID hit the news, the U.S. Preventative Services Task Force, on
Oct. 12, posted draft recommendations saying that, “Once people turn
60 years old, they should not consider starting to take aspirin
because the risk of bleeding cancels out the benefits of preventing
heart disease.” What curious timing.

Certainly, aspirin has potential side effects including an increased
risk of bleeding. All medications have side effects and one can even
die from drinking too much water. It always comes down to medical
decision-making, balancing risks and benefits, in consultation with
one’s healthcare provider.

The media wasted no time in using the suddenly released and new
aspirin recommendations at the same time as news reports on aspirin
benefits for COVID hit the news.

NBC reported, “Most adults shouldn't take daily aspirin to prevent
heart attack, panel says.” The New York Times echoed, “Daily low-dose
aspirin no longer recommended by doctors, if you’re healthy.”
Healthline went further, “Doctors warn daily aspirin use can be
dangerous.” Driving or walking across the street can be dangerous too.

Sound familiar? How many adults have been taking low-dose aspirin
daily for many years, based on the decades-old Harvard study? I have
as I have a family history of cardiovascular disease and my internist
and I agree that the benefits outweigh the risks, despite the new
recommendations.

Similarly how many patients have been taking hydroxychloroquine for
years or decades for arthritis or lupus, without dying from the drug
as Fox News crank Neil Cavuto warned last year? How many take
ivermectin to prevent parasitic infections? Now we can add aspirin to
the list of once safe and effective medications -- that's now on par
with cyanide or strychnine.

It seems the medical establishment and the media want to squash any
potential COVID therapeutic, especially the inexpensive ones, instead
pushing vaccines and extremely pricey medicines like Merck’s new $712
COVID drug.

The media described ivermectin as horse dewormer or animal paste,
seemingly unaware that it is an FDA-approved medication for human use
and was once honored with a Nobel Prize. Watch Joe Rogan put CNN’s
medical mouthpiece, Dr. Sanjay Gupta, in a virtual chokehold until he
tapped out and admitted to CNN’s irresponsible reporting and lying
about ivermectin.

Aspirin also has non-medical uses including as a stain remover, garden
enhancer, and dandruff remedy. I would love to hear President Trump
mention the potential benefits of aspirin for COVID and see the news
headlines of Trump recommending people ingest detergent, fertilizer,
or shampoo to treat COVID.

Welcome to simple aspirin, the media’s new horse dewormer.

Brian C. Joondeph, M.D., is a physician and writer. On Twitter and
FreeAtlantis as @retdoc.


More information about the cypherpunks mailing list